A pharmaceutical company could fund the creation of an app to promote gambling, alcohol, unhealthy processed food, with claims that an ersatz dairy spread can reduce cholesterol and the risk of cardiovascular disease, and missile systems. It would be entirely lawful. However, it could not lawfully promote its approved therapeutic products on the app, while virtually everyone else is free to discuss them.
This regulatory restriction is too harmful to be described as simply outdated
January 25, 2026 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
Major brands and biosimilars feature prominently on November PBAC agenda
July 23, 2026 - - Latest News -
Bellberry and ASCEPT release checklist for 'new approach methodologies' trials
July 23, 2026 - - Latest News -
Faster processes could push Pharmac's options for investment backlog to 400 within two years
July 23, 2026 - - Latest News -
How national HPV vaccination programs are changing the story of cervical cancer
July 23, 2026 - - Latest News -
BLS and Trexapharm move to bring TREXAVIVE to Australian patients
July 22, 2026 - - BioPharma -
Radiopharm Theranostics reports positive results in tumour trials
July 22, 2026 - - Australian Biotech -
Proteomics International and Healius team up to take Promarker tests national
July 22, 2026 - - Australian Biotech

